Focusing Management Resources Through the Transfer of the Medical & Anti-Aging Business
First written in FY2022-Q2. 5 of 10 entries say "Advanced", first in FY2024. Latest entry: 2026-06-26.
25 other companies' latest entry also says "Cited as achieved".
- 2026-06-26Cited as achievedManagement Planning
「We concluded that the above 3 companies were unlikely to generate the originally expected synergies, and sold all shares held in them as of 31 March 2026, excluding them from the scope of consolidation.」
The Company cites the existing strategy of selecting and concentrating management resources and reviewing the business structure as an accomplished sale and exclusion from consolidation of the 3 companies. - FY2026AdvancedAnnual report
「To improve business efficiency and concentrate management resources, we have decided to exclude 株式会社エンジニアファーム, 株式会社バニヤンズ and TENJIN SYSTEM CONSULTING Co., Ltd. from consolidation.」
The company has implemented the sale of all shares in 3 companies and their exclusion from consolidation, giving concrete form to the restructuring of its business portfolio through the selective concentration of management resources. - FY2024AdvancedAnnual report
「We reviewed the profitability of existing projects and improved performance by withdrawing from the unprofitable projects we had previously pursued, selectively concentrating on more profitable projects, and strengthening profitability management for each project.」
Regarding the review of businesses with deteriorating profitability, the company states that it withdrew from unprofitable projects, concentrated on more profitable projects, and implemented project-level profitability management, resulting in improvement. - FY2024-Q2RestatedAnnual report
「① Review of businesses with deteriorating profitability」
The company continues to identify the review of businesses with deteriorating profitability as a key measure in its medium-term management plan. - FY2023-Q3RestatedAnnual report
「① Review of businesses with deteriorating profitability」
Following the selective concentration of resources through the transfer of the Medical & Anti-Aging business, the company continues to pursue the review of businesses with deteriorating profitability as a key measure in its medium-term management plan. - FY2023-Q1RestatedAnnual report
「① Review of businesses with deteriorating profitability」
Following the selective concentration of resources through the transfer of the Medical & Anti-Aging business in the previous fiscal year, the company has identified the review of businesses with deteriorating profitability as a key measure in its medium-term management plan. - FY2022-Q2First statedAnnual report
「Our group is pursuing fundamental reforms with the aim of achieving continued business expansion, but we determined that expanding the Medical & Anti-Aging business operated by 株式会社マーベラント would require substantial investment and time. We determined that transferring all shares in the company would improve management efficiency through the selective concentration of management resources and contribute to enhancing the overall corporate value of our group.」
The company determined that expanding the Medical & Anti-Aging business would require substantial investment and time, and identified the selective concentration of management resources through the transfer of all shares, greater management efficiency and improved corporate value as the reasons for the business restructuring.